These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27579980)

  • 1. Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery.
    Saigusa D; Okamura Y; Motoike IN; Katoh Y; Kurosawa Y; Saijyo R; Koshiba S; Yasuda J; Motohashi H; Sugawara J; Tanabe O; Kinoshita K; Yamamoto M
    PLoS One; 2016; 11(8):e0160555. PubMed ID: 27579980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample normalization methods in quantitative metabolomics.
    Wu Y; Li L
    J Chromatogr A; 2016 Jan; 1430():80-95. PubMed ID: 26763302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of isotope labeling liquid chromatography mass spectrometry for mouse urine metabolomics: quantitative metabolomic study of transgenic mice related to Alzheimer's disease.
    Peng J; Guo K; Xia J; Zhou J; Yang J; Westaway D; Wishart DS; Li L
    J Proteome Res; 2014 Oct; 13(10):4457-69. PubMed ID: 25164377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS-based holistic metabolic profiling. Problems, limitations, advantages, and future perspectives.
    Gika HG; Wilson ID; Theodoridis GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():1-6. PubMed ID: 24618029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS Untargeted Analysis.
    Want EJ
    Methods Mol Biol; 2018; 1738():99-116. PubMed ID: 29654585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-Mass Spectrometry for Metabolomics.
    Dailey AL
    Methods Mol Biol; 2017; 1606():333-340. PubMed ID: 28502010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Isotope Labeling LC-MS for Human Blood Metabolome Analysis.
    Han W; Li L
    Methods Mol Biol; 2018; 1730():213-225. PubMed ID: 29363075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated use of LC/MS/MS and LC/Q-TOF/MS targeted metabolomics with automated label-free microscopy for quantification of purine metabolites in cultured mammalian cells.
    Nybo SE; Lamberts JT
    Purinergic Signal; 2019 Mar; 15(1):17-25. PubMed ID: 30604179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
    Gika HG; Theodoridis GA; Plumb RS; Wilson ID
    J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing and Performing Targeted Multi-residue Analysis for Lipid Mediators and Fatty Acids in Small Clinical Plasma Samples.
    Pedersen TL; Newman JW
    Methods Mol Biol; 2018; 1730():175-212. PubMed ID: 29363074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization study for metabolomics analysis of human sweat by liquid chromatography-tandem mass spectrometry in high resolution mode.
    Calderón-Santiago M; Priego-Capote F; Jurado-Gámez B; Luque de Castro MD
    J Chromatogr A; 2014 Mar; 1333():70-8. PubMed ID: 24529403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and vintage solutions to enhance the plasma metabolome coverage by LC-ESI-MS untargeted metabolomics: the not-so-simple process of method performance evaluation.
    Tulipani S; Mora-Cubillos X; Jáuregui O; Llorach R; García-Fuentes E; Tinahones FJ; Andres-Lacueva C
    Anal Chem; 2015 Mar; 87(5):2639-47. PubMed ID: 25642801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discovery.
    Shao Y; Zhu B; Zheng R; Zhao X; Yin P; Lu X; Jiao B; Xu G; Yao Z
    J Proteome Res; 2015 Feb; 14(2):906-16. PubMed ID: 25483141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-saving design of experiment protocol for optimization of LC-MS data processing in metabolomic approaches.
    Zheng H; Clausen MR; Dalsgaard TK; Mortensen G; Bertram HC
    Anal Chem; 2013 Aug; 85(15):7109-16. PubMed ID: 23841659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of XCMS parameters for LC-MS metabolomics: an assessment of automated versus manual tuning and its effect on the final results.
    Albóniga OE; González O; Alonso RM; Xu Y; Goodacre R
    Metabolomics; 2020 Jan; 16(1):14. PubMed ID: 31925557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.